Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C MacDougall

Showing results (311-320 of 373) with videos related to

Pageof 38
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 3, 2014
Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot studyHelen L MacLaughlin, Wendy L Hall, Ameet G Patel, et al.
Medicine and Science in Sports and Exercise|July 23, 2013
Intravenous iron supplementation in distance runners with low or suboptimal ferritinLaura A Garvican, Philo U Saunders, Tanusha Cardoso, et al.
Plos One|June 9, 2016
Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD TrialCarlo A Gaillard, Andreas H Bock, Fernando Carrera, et al.
Environment International|December 13, 2021
Gestational exposure to polybrominated diphenyl ethers and social skills and problem behaviors in adolescents: The HOME studyKim Hartley, Melinda C MacDougall, Brandon Terrizzi, et al.
Oncology (Williston Park, N.Y.)|April 17, 2010
Reassessments of ESAs for cancer treatment in the US and EuropeCharles L Bennett, June M McKoy, Michael Henke, et al.
Kidney International|February 17, 2012
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insightsIain C Macdougall, Simon D Roger, Angel de Francisco, et al.
European Heart Journal|November 27, 2012
Iron status in patients with chronic heart failureEwa A Jankowska, Jolanta Malyszko, Hossein Ardehali, et al.
American Journal of Nephrology|February 5, 2023
Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)Iain C Macdougall, Amy M Meadowcroft, Allison Blackorby, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 8, 2011
Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trialEldrin F Lewis, Marc A Pfeffer, Amy Feng, et al.
Circulation|July 14, 2017
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron DeficiencyDirk J van Veldhuisen, Piotr Ponikowski, Peter van der Meer, et al.
Pageof 38

Showing results (311-320 of 373) with videos related to

Sort By:
Pageof 38
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 3, 2014
Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot studyHelen L MacLaughlin, Wendy L Hall, Ameet G Patel, et al.
Medicine and Science in Sports and Exercise|July 23, 2013
Intravenous iron supplementation in distance runners with low or suboptimal ferritinLaura A Garvican, Philo U Saunders, Tanusha Cardoso, et al.
Plos One|June 9, 2016
Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD TrialCarlo A Gaillard, Andreas H Bock, Fernando Carrera, et al.
Environment International|December 13, 2021
Gestational exposure to polybrominated diphenyl ethers and social skills and problem behaviors in adolescents: The HOME studyKim Hartley, Melinda C MacDougall, Brandon Terrizzi, et al.
Oncology (Williston Park, N.Y.)|April 17, 2010
Reassessments of ESAs for cancer treatment in the US and EuropeCharles L Bennett, June M McKoy, Michael Henke, et al.
Kidney International|February 17, 2012
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insightsIain C Macdougall, Simon D Roger, Angel de Francisco, et al.
European Heart Journal|November 27, 2012
Iron status in patients with chronic heart failureEwa A Jankowska, Jolanta Malyszko, Hossein Ardehali, et al.
American Journal of Nephrology|February 5, 2023
Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)Iain C Macdougall, Amy M Meadowcroft, Allison Blackorby, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 8, 2011
Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trialEldrin F Lewis, Marc A Pfeffer, Amy Feng, et al.
Circulation|July 14, 2017
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron DeficiencyDirk J van Veldhuisen, Piotr Ponikowski, Peter van der Meer, et al.
Pageof 38